“Safety does not come with luck. It must be prepared” – Pharmacovigilance Report

Our latest industry analytics report features analysis on the drug safety sector within the life sciences industry. Clinical Professionals Group CEO, Yvette Cleland comments: “The global pharmacovigilance (PV) market size was estimated at $4.87 billion in 2019, according to a Global Market Insights report, by 2024 the market is predicted to exceed US$8 billion .

Continue Reading

Karyopharm announce Xpovio meets endpoints in Phase III trial

The pharmaceutical company announced positive top-line results from the randomised Phase III BOSTON study of Xpovio (selinexor). The drug in combination with once-weekly Velcade (bortezomib) and low-dose dexamethasone (SVd) met its primary endpoint of a statistically significant increase in progression-free survival (PFS) compared to standard twice-weekly Velcade plus low-dose dexamethasone (Vd). The trial saw the

Continue Reading

RIX interview Yvette Cleland on “What are the top staffing and recruitment trends for 2020?”​

Yvette Cleland, Clinical Professionals Group CEO was recently asked by RIX (Recruitment Innovation Exchange) to provide her insights on the next biggest trends for 2020 for the staffing and recruitment industry, and to provide advice to firms looking to kickstart the new year. What industry trend is going to have the most impact for staffing and

Continue Reading